Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
may be involved in cartilage development [RGD, Feb 2006].. Additionally we are shipping Melanoma Inhibitory Activity Protein 1 Kits (14) and Melanoma Inhibitory Activity Protein 1 Proteins (3) and many more products for this protein.
Showing 3 out of 4 products:
MIA (show MIA Antibodies) had a slightly superior sensitivity to detect progressive disease compared to S100 and seems to be more useful in monitoring of patients with metastatic melanoma receiving immunotherapy
real-time RT-PCR assays showed that expressions of MIA (show MIA Antibodies) and MIA (show MIA Antibodies)-RAB4B (show RAB4B Antibodies) located 35 kb upstream of the deletion, were up-regulated in the polyps compared to the matched mucosa of the proband. MIA (show MIA Antibodies)-RAB4B (show RAB4B Antibodies), the read-through long non-coding RNA (lncRNA), RAB4B (show RAB4B Antibodies), PIM2 (show PIM2 Antibodies) and TAOK1 (show TAOK1 Antibodies) share common binding site of a microRNA, miR (show MLXIP Antibodies)-24, in their 3'UTRs
The effects of MIA/CD-RAP (show MIA Antibodies) on transcriptional regulation in chondrocytes, through the regulation of p54(nrb (show NONO Antibodies)) via YBX1 (show YBX1 Antibodies) contributes to the understanding of chondrogenesis.
data provide evidence for a critical role of SOX10 (show SOX10 Antibodies) in melanoma cell invasion through the regulation of MIA (show MIA Antibodies) and highlight its role as a therapeutic target in melanoma
Focus on the quantitative analysis of the MIA (show MIA Antibodies) protein as a prognostic tool because it has proven to be a useful serum marker for documenting disease progression of malignant melanoma. Review.
Functional promoter analysis identified the transcription factor YBX1 (show YBX1 Antibodies) as the mediator of MIA (show MIA Antibodies) activation of p54(nrb (show NONO Antibodies)) transcription.
MIA (show MIA Antibodies) protein is present in non-segmental vitiligo (show MITF Antibodies) skin and may cause the detachment of melanocytes; its target is integrin alpha5beta1, which determines the breaking and/or weakening of connections among melanocytes and basal membrane
Results show that S-100B, MIA and LDH levels were significantly higher in patients with advanced melanoma than in disease-free patients or healthy controls.
assessed the utility of melanoma inhibitory activity (MIA (show MIA Antibodies)) serum marker in the follow up and primary diagnosis of stage III melanoma patients
Further diagnostics should be initiated in uveal melanoma patients with serum MIA (show MIA Antibodies) above 8.3ng/ml.
may be involved in cartilage development
melanoma-derived growth regulatory protein
, melanoma inhibitory activity 1
, melanoma inhibitory activity protein
, cartilage derived retinoic acid sensitive protein
, cartilage-derived retinoic acid-sensitive protein
, melanoma inhibitory activity/condrocyte-derived retinoic acid sensitive protein homolog (MIA/CD-RAP)